Literature DB >> 11381499

Expression of cathepsin B and cystatin C in human breast cancer.

M Yano1, K Hirai, Z Naito, M Yokoyama, T Ishiwata, Y Shiraki, M Inokuchi, G Asano.   

Abstract

Cathepsin B, which was originally found to be a lysosomal cysteine protease, is also an important matrix protease. In this study, we investigated the expression of cathepsin B and cystatin C, the strongest inhibitor of cathepsin B, and measured the relative amounts of each in human breast cancer tissues. Cystatin C expression relative to cathepsin B expression was found to be decreased. This finding could be associated with the looseness of cancerous interstitial tissue, which might play a role in cancer invasion and metastasis. This report documents the first simultaneous investigation of cathepsin B and cystatin C in breast cancer tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381499     DOI: 10.1007/s005950170126

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.

Authors:  Maode Wang; Jianjian Tang; Shouxun Liu; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 2.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

3.  Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.

Authors:  Kanako Shibata; Yoshinari Yasuda; Ryo Kobayashi; Yuichi Ando; Tomoya Shimokata; Hideki Kamiya; Mutsuharu Hayashi; Shoichi Maruyama; Seiichi Matsuo; Makoto Nakao; Teruo Tsuchiya; Hitomi Teramachi
Journal:  Clin Exp Nephrol       Date:  2015-04-19       Impact factor: 2.801

4.  Microdialysis combined with proteomics for protein identification in breast tumor microenvironment in vivo.

Authors:  Baogang J Xu; Wenwei Yan; Bojana Jovanovic; Aubie K Shaw; Qi A An; Jimmy Eng; Anna Chytil; Andrew J Link; Harold L Moses
Journal:  Cancer Microenviron       Date:  2010-04-13

Review 5.  Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.

Authors:  Daan G J Linders; Okker D Bijlstra; Laura C Fallert; Denise E Hilling; Ethan Walker; Brian Straight; Taryn L March; A Rob P M Valentijn; Martin Pool; Jacobus Burggraaf; James P Basilion; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2022-08-24       Impact factor: 3.484

6.  Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma.

Authors:  Yan Yan; Kun Zhou; Liping Wang; Yue Zhou; Xinfeng Chen; Qingxia Fan
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Cathepsin D is up-regulated in inflammatory bowel disease macrophages.

Authors:  M Hausmann; F Obermeier; K Schreiter; T Spottl; W Falk; J Schölmerich; H Herfarth; P Saftig; G Rogler
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

8.  A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.

Authors:  Wen-Lin Kuo; Debopriya Das; Safiyyah Ziyad; Sanchita Bhattacharya; William J Gibb; Laura M Heiser; Anguraj Sadanandam; Gerald V Fontenay; Zhi Hu; Nicholas J Wang; Nora Bayani; Heidi S Feiler; Richard M Neve; Andrew J Wyrobek; Paul T Spellman; Laurence J Marton; Joe W Gray
Journal:  BMC Med       Date:  2009-12-14       Impact factor: 8.775

9.  Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors.

Authors:  Eva Kolwijck; Leon F A G Massuger; Chris M G Thomas; Paul N Span; Marta Krasovec; Janko Kos; Fred C G J Sweep
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-14       Impact factor: 4.553

10.  Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.

Authors:  P Strojan; I Oblak; B Svetic; L Smid; J Kos
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.